ES530846A0 - Agentes antimicoticos con elevada liberacion del producto activo - Google Patents

Agentes antimicoticos con elevada liberacion del producto activo

Info

Publication number
ES530846A0
ES530846A0 ES530846A ES530846A ES530846A0 ES 530846 A0 ES530846 A0 ES 530846A0 ES 530846 A ES530846 A ES 530846A ES 530846 A ES530846 A ES 530846A ES 530846 A0 ES530846 A0 ES 530846A0
Authority
ES
Spain
Prior art keywords
active product
high release
antimicotic
agents
antimicotic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES530846A
Other languages
English (en)
Other versions
ES8503947A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES530846A0 publication Critical patent/ES530846A0/es
Publication of ES8503947A1 publication Critical patent/ES8503947A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES530846A 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo Expired ES8503947A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311701 DE3311701A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme

Publications (2)

Publication Number Publication Date
ES530846A0 true ES530846A0 (es) 1985-04-16
ES8503947A1 ES8503947A1 (es) 1985-04-16

Family

ID=6195162

Family Applications (3)

Application Number Title Priority Date Filing Date
ES530846A Expired ES8503947A1 (es) 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo
ES539289A Granted ES539289A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
ES539290A Granted ES539290A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES539289A Granted ES539289A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
ES539290A Granted ES539290A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo

Country Status (19)

Country Link
JP (1) JPS59184106A (es)
KR (1) KR840008284A (es)
AU (1) AU564956B2 (es)
BE (1) BE899278A (es)
CA (1) CA1212327A (es)
CH (1) CH660126A5 (es)
CY (1) CY1358A (es)
DE (1) DE3311701A1 (es)
ES (3) ES8503947A1 (es)
FR (1) FR2543435B1 (es)
GB (1) GB2137091B (es)
GR (1) GR81485B (es)
IT (1) IT1173761B (es)
KE (1) KE3704A (es)
LU (1) LU85271A1 (es)
PH (1) PH20420A (es)
PT (1) PT78313B (es)
SE (1) SE8401748L (es)
ZA (1) ZA842337B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ZA934007B (en) * 1992-06-08 1994-03-09 Schering Plough Healthcare Stable imidazole anti-fungal powder compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
CY1358A (en) 1987-08-07
SE8401748L (sv) 1984-10-01
CA1212327A (en) 1986-10-07
IT1173761B (it) 1987-06-24
ES8601692A1 (es) 1985-11-16
GB8408067D0 (en) 1984-05-10
GR81485B (es) 1984-12-11
JPS59184106A (ja) 1984-10-19
DE3311701A1 (de) 1984-10-04
ES8601693A1 (es) 1985-11-16
SE8401748D0 (sv) 1984-03-29
CH660126A5 (de) 1987-03-31
BE899278A (fr) 1984-10-01
AU2623684A (en) 1984-10-04
PH20420A (en) 1987-01-05
FR2543435B1 (fr) 1988-06-17
PT78313A (en) 1984-04-01
KE3704A (en) 1987-03-27
IT8420303A0 (it) 1984-03-29
ZA842337B (en) 1984-11-28
PT78313B (en) 1986-06-02
GB2137091B (en) 1986-10-01
ES539289A0 (es) 1985-11-16
ES8503947A1 (es) 1985-04-16
LU85271A1 (de) 1984-11-14
KR840008284A (ko) 1984-12-14
GB2137091A (en) 1984-10-03
ES539290A0 (es) 1985-11-16
AU564956B2 (en) 1987-09-03
FR2543435A1 (fr) 1984-10-05

Similar Documents

Publication Publication Date Title
IT1130649B (it) Dispositivo dosatore per dosare e travasare,in assenza di germi,prodotto liquido
HU173318B (hu) Mikrobicidnye kompozicii soderzhahhie proizvodnye acetanilida i sposob poluchenija aktivnogo agenta
LU81133A1 (de) Cerebralwirksames mittel
IT7953060V0 (it) Indicatore del carico applicatoparticolarmente per cinture di sicurezza
JPS5364992A (en) Sterilizing bandage
IT8067896A0 (it) Telaio per sedia impilabile e sedia dotata del telaio stesso
IT1129802B (it) Agente antitumorale
IT8249457A0 (it) Derivati del ciclopropano, loro procedimento di preparazione, loro impiego come agenti profumanti e composizioni che li contengono
AU3125677A (en) Active microbecidal compositions
HU177972B (en) Fungicide composition and process for producing the active agent
DK345383A (da) Rensemiddel, der giver antistatiske egenskaber
ES492668A0 (es) Procedimiento de estabilizacion y regeneracion del cataliza-dor de hidroformilacion del propeno
EP0024023A3 (en) Antimycotic agents with enhanced release of the active ingredients
ES530845A0 (es) Agentes antimicoticos con elevada liberacion del producto activo
IT8022385A0 (it) Agenti per la gelificazione di fluoroelastomeri e prodotti con essi ottenuti.
ES530846A0 (es) Agentes antimicoticos con elevada liberacion del producto activo
HU177937B (en) Insecticide compositions containing n,n-dimethyl-o-pyrazolyl-carbamoic-acid-esters and process for producing the active agents
JPS52148627A (en) Medicine having antiiarrhythmia active prorerty
IT1158004B (it) Apparecchio e procedimento per l'impilamento di articoli di forma appiattita particolarmente pannolini ed assorbenti
IT1089233B (it) O-propilossime sostituite con sostituenti basici,procedimento per la loro preparazione e loro impiego come prodotti medicinali
IT9059338V0 (it) Struttura di dispositivo di bloccaggio, particolarmente durarnte il trascinamento del cartone
IT1163077B (it) Peptide e agente ormonale contenente lo stesso come ingrendiente attivo
IT1174476B (it) Agente antitumorale
NO153731C (no) Fremgangsmaate for isolering av fysiologisk aktive pterocarpanforbindelser i krystallinsk form.
IT1143727B (it) Procedimento per la preparazione di derivati del morfinano 3-fenossi-n-sostituiti e relativi prodotti